{"id":"https://genegraph.clinicalgenome.org/r/50b1c40f-c0ed-4774-8ba3-65d54107fdddv1.0","type":"EvidenceStrengthAssertion","dc:description":"CIB2 was first reported in relation to autosomal recessive Usher syndrome Type 1 in 2012 (Riazuddin et al., 23023331). One homozygous missense variants in this gene has been reported in at least one proband in one publication (Riazuddin et al. 2012, 23023331). Variants in this gene segregated with disease in 3 additional family members. One additional missense variant has been reported in heterozygosity in an affected individual, however the variant is frequent in population databases and no second pathogenic variant was identified (Fuster-Garcia et al. 2018, 30459346).\nBooth et al. 2017 (29112224) studied a multi-ethnic cohort of patients with CIB2-related-ARNSHL. All patients in this study have normal ocular phenotype and no vestibular dysfunction regardless of the variant impact. Booth et al. 2017 note that the p.Glu64Asp variant in the Riazuddin Usher family is only two amino acids away from the p.Arg66Trp variant that has been linked to ARNSHL in three families. Booth et al. argue that if CIB2 played a role in Usher syndrome, we would expect to see a retinal and vestibular phenotype in families segregating LOF variants. Michel et al. 2017 (29084757) described 2 families with CIB2-related-ARNSHL. Both families segregate LOF variants and have normal eye phneotype with no pigment deposits. In addition to the variants reported by Booth and Michel, 7 other variants have been linked solely to CIB2-related-ARNSHL (see the CIB2 and ARNSHL gene-disease pair). Michel et al. 2017 also described a CIB2 knockout mouse model. This mouse model displayed congenital profound deafness with no vestibular defect. It also exhibited normal cochlear hair bundle architecture up to postnatal day 7. This is in contrast with all other known USH1 mouse models, which display severe vestibular dysfunction and abnormal cochlear hair bundle architecture starting around postnatal day 3. Other CIB2-murine mutants (28663585 and 29255404) display an identical phenotype to that described by Michel et al. Additionally, it was shown that loss of known USH proteins like MYO7A, PCDH15, USH1C, WHRN, USH2A and PDZD7 does not affect the localization of CIB2, and vice versa. In summary, there is convincing evidence refuting the relationship between CIB2 and autosomal recessive Usher syndrome Type 1, which significantly outweighs the evidence supporting the relationship. This classification was approved by the ClinGen Hearing Loss Working Group on 02/19/2019.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/50b1c40f-c0ed-4774-8ba3-65d54107fddd","GCISnapshot":"https://genegraph.clinicalgenome.org/r/95709038-78a4-4043-a054-9cbe245d2588","calculatedEvidenceStrength":"Limited","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/95709038-78a4-4043-a054-9cbe245d2588_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10007","date":"2019-02-19T17:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/95709038-78a4-4043-a054-9cbe245d2588_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10007","date":"2020-09-01T00:00:00Z","role":"Publisher"}],"curationReasonDescription":"Booth et al. 2017 notes that the p.Glu64Asp variant in the Usher family is only two amino acids away from the p.Arg66Trp variant that has been linked to ARNSHL in three families. All patients studied by Booth et al. 2017 with CIB2 related ARNSHL have normal ocular phenotype no matter the variant impact (null or missense). Booth et al. argue that if CIB2 played a role in Usher syndrome, we would expect to see a retinal phenotype in families segregating with LOF variants. Additionally, loss of known Usher proteins like MYO7A, PCDH15, USH1C, WHRN, USH2A and PDZD7 do not affect the localization of CIB2, and vice versa. Finally, mouse models of Usher caused known Usher genes display congenital profound deafness and vestibular dysfunction, while CIB2 mouse models do not display vestibular disfunction.","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/95709038-78a4-4043-a054-9cbe245d2588_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/95709038-78a4-4043-a054-9cbe245d2588_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/93494474-3409-4f8c-bbb7-50ccc51ba2ac_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23023331","rdfs:label":"PKDF117","estimatedLodScore":1.81,"family":{"id":"https://genegraph.clinicalgenome.org/r/93494474-3409-4f8c-bbb7-50ccc51ba2ac","type":"Family","rdfs:label":"PKDF117","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/ef301035-d92a-46d4-8f2e-97eda7ab3e90","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23023331","rdfs:label":"PKDF117 Proband","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"linkage analysis, sequenced all 16 candidate genes","firstTestingMethod":"Linkage analysis","previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/424fd6df-b048-42b4-b2af-ec503e5b05ae_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23023331","allele":{"id":"https://genegraph.clinicalgenome.org/r/d101262c-bc5d-4ce0-87bc-086202562ab0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006383.3(CIB2):c.192G>C (p.Glu64Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/39688"}}}}},"phenotypeFreeText":"","phenotypeNegativeAlleleNegative":0,"phenotypePositiveAllelePositive":4,"proband":{"id":"https://genegraph.clinicalgenome.org/r/ef301035-d92a-46d4-8f2e-97eda7ab3e90"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/00e489cf-4e3a-46a7-8d7f-d6367e86cd9b_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This individual cannot be scored for multiple reasons. The p.Arg104Gln variant is present in 76/25108 (0.3%) of European (Finnish) alleles and 33/128914 (0.2%) European (Non-Finnish) alleles in gnomAD, which is considered benign for both AD and AR hearing loss. No second variant was identified in this individual. The individual's phenotypes were not described beyond \"unspecified\" Usher syndrome. The individual was not tested for many other causative hearing loss genes.","direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ee1eacc5-cfdf-439a-82bd-3b50c09b6b0f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30459346","rdfs:label":"RP1571","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"targeted exome panel including the following: MYO7A, USH1C, CDH23, PCDH15, USH1G, CIB2, USH2A, ADGRV1, WHRN, CLRN1, HARS, PDZD7, CEP250, C2orf71, and a locus containing the c.7595â€“ 2144A>G intronic mutation in USH2A","firstTestingMethod":"Exome sequencing","previousTesting":false,"previousTestingDescription":"","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/00e489cf-4e3a-46a7-8d7f-d6367e86cd9b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30459346","allele":{"id":"https://genegraph.clinicalgenome.org/r/059ba505-c37d-431b-8fae-1434eb77c309","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000015.10:g.78109270C>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7680235"}}}}],"specifiedBy":"GeneValidityUncategorizedProbandCriteria"},{"id":"https://genegraph.clinicalgenome.org/r/424fd6df-b048-42b4-b2af-ec503e5b05ae_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Variant present in 1/30614 (0.003%) South Asian alleles in gnomAD. Downgraded to be conservative of consanguineous family.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ef301035-d92a-46d4-8f2e-97eda7ab3e90"}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/95709038-78a4-4043-a054-9cbe245d2588_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/95709038-78a4-4043-a054-9cbe245d2588_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6803141c-73d3-4e80-8ee4-8d8903808cbb","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/64cf81f1-d662-49c7-a237-ae2e175e500e","type":"FunctionalAlteration","dc:description":"conclude that the p.E64D variant in CBI2 causes an inability of the CIB2 mutant to switch to its native Mg2+-bound conformation which is necessary for normal function","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30174586","rdfs:label":"Vallone Function"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":0.5}],"evidenceStrength":"Refuted","sequence":502,"specifiedBy":"GeneValidityCriteria6","strengthScore":1,"subject":{"id":"https://genegraph.clinicalgenome.org/r/-6f9ru5rZVo","type":"GeneValidityProposition","disease":"obo:MONDO_0010168","gene":"hgnc:24579","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_95709038-78a4-4043-a054-9cbe245d2588-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}